Concepts (111)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Flavin-Adenine Dinucleotide | 8 | 2025 | 9 | 2.860 |
Why?
|
| Fatty Acid Desaturases | 3 | 2025 | 5 | 2.410 |
Why?
|
| Riboflavin | 7 | 2025 | 14 | 2.320 |
Why?
|
| Carcinoma, Pancreatic Ductal | 2 | 2025 | 105 | 1.670 |
Why?
|
| Multiple Acyl Coenzyme A Dehydrogenase Deficiency | 2 | 2022 | 2 | 1.550 |
Why?
|
| Pancreatic Neoplasms | 2 | 2025 | 326 | 1.440 |
Why?
|
| Histone Demethylases | 1 | 2025 | 11 | 0.960 |
Why?
|
| Flavins | 1 | 2024 | 22 | 0.920 |
Why?
|
| Homeostasis | 2 | 2024 | 343 | 0.920 |
Why?
|
| Trace Elements | 1 | 2023 | 18 | 0.890 |
Why?
|
| Neuromuscular Diseases | 2 | 2021 | 23 | 0.880 |
Why?
|
| Metabolic Diseases | 1 | 2023 | 52 | 0.850 |
Why?
|
| Recombinant Proteins | 3 | 2025 | 696 | 0.820 |
Why?
|
| Sarcoidosis | 1 | 2023 | 30 | 0.820 |
Why?
|
| Educational Measurement | 1 | 2024 | 213 | 0.810 |
Why?
|
| Nucleotidyltransferases | 2 | 2024 | 54 | 0.790 |
Why?
|
| Pulmonary Edema | 1 | 2022 | 25 | 0.780 |
Why?
|
| Riboflavin Deficiency | 1 | 2020 | 1 | 0.710 |
Why?
|
| Flavoproteins | 1 | 2020 | 29 | 0.700 |
Why?
|
| Curriculum | 1 | 2024 | 569 | 0.690 |
Why?
|
| Radiology | 1 | 2024 | 233 | 0.690 |
Why?
|
| Muscle Proteins | 1 | 2020 | 110 | 0.670 |
Why?
|
| Melanoma | 1 | 2023 | 334 | 0.650 |
Why?
|
| Clinical Competence | 1 | 2024 | 698 | 0.640 |
Why?
|
| Flavin Mononucleotide | 4 | 2022 | 9 | 0.630 |
Why?
|
| Escherichia coli | 2 | 2025 | 688 | 0.560 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2021 | 400 | 0.540 |
Why?
|
| Internship and Residency | 1 | 2024 | 746 | 0.540 |
Why?
|
| Muscle, Skeletal | 1 | 2021 | 678 | 0.510 |
Why?
|
| Neurons | 1 | 2021 | 861 | 0.480 |
Why?
|
| Models, Biological | 1 | 2020 | 1141 | 0.480 |
Why?
|
| Caenorhabditis elegans | 1 | 2021 | 622 | 0.480 |
Why?
|
| Heart Failure | 1 | 2022 | 869 | 0.450 |
Why?
|
| Neoplasms | 1 | 2024 | 1260 | 0.450 |
Why?
|
| Humans | 18 | 2025 | 60049 | 0.450 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2025 | 299 | 0.390 |
Why?
|
| Cloning, Molecular | 2 | 2021 | 385 | 0.340 |
Why?
|
| Cell Line, Tumor | 2 | 2025 | 1380 | 0.340 |
Why?
|
| Membrane Transport Proteins | 2 | 2025 | 121 | 0.280 |
Why?
|
| Kidney Tubules, Collecting | 1 | 2005 | 6 | 0.250 |
Why?
|
| Aquaporins | 1 | 2005 | 6 | 0.250 |
Why?
|
| Intracellular Membranes | 1 | 2005 | 50 | 0.240 |
Why?
|
| Hearing Loss, Sensorineural | 2 | 2022 | 46 | 0.240 |
Why?
|
| Proteolipids | 1 | 2025 | 24 | 0.240 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2024 | 48 | 0.230 |
Why?
|
| Protein Multimerization | 2 | 2024 | 168 | 0.220 |
Why?
|
| Micronutrients | 1 | 2023 | 29 | 0.220 |
Why?
|
| Radiography, Thoracic | 1 | 2024 | 102 | 0.220 |
Why?
|
| Catalytic Domain | 1 | 2024 | 193 | 0.210 |
Why?
|
| Proteomics | 1 | 2005 | 262 | 0.210 |
Why?
|
| Fatty Acids | 1 | 2023 | 194 | 0.200 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2025 | 484 | 0.200 |
Why?
|
| Exons | 1 | 2022 | 193 | 0.190 |
Why?
|
| Neoplastic Stem Cells | 1 | 2023 | 202 | 0.190 |
Why?
|
| Animals | 4 | 2024 | 19729 | 0.190 |
Why?
|
| Education, Medical, Graduate | 1 | 2024 | 319 | 0.190 |
Why?
|
| Dietary Supplements | 1 | 2023 | 249 | 0.180 |
Why?
|
| Vitamins | 1 | 2021 | 82 | 0.180 |
Why?
|
| Metabolism, Inborn Errors | 1 | 2021 | 21 | 0.180 |
Why?
|
| Chromatography, Affinity | 1 | 2021 | 48 | 0.180 |
Why?
|
| Fluorescence | 1 | 2021 | 84 | 0.180 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2021 | 127 | 0.170 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2021 | 197 | 0.170 |
Why?
|
| Stroke Volume | 1 | 2022 | 323 | 0.170 |
Why?
|
| Ventricular Function, Left | 1 | 2022 | 264 | 0.170 |
Why?
|
| Artificial Intelligence | 1 | 2022 | 173 | 0.170 |
Why?
|
| Models, Molecular | 1 | 2024 | 1129 | 0.170 |
Why?
|
| Gene Expression | 1 | 2023 | 807 | 0.170 |
Why?
|
| Neoplasms, Glandular and Epithelial | 1 | 2019 | 13 | 0.170 |
Why?
|
| Thymus Neoplasms | 1 | 2019 | 21 | 0.170 |
Why?
|
| Protein Binding | 1 | 2024 | 1561 | 0.160 |
Why?
|
| Neurodegenerative Diseases | 1 | 2021 | 128 | 0.160 |
Why?
|
| Mitochondria | 1 | 2022 | 337 | 0.160 |
Why?
|
| Predictive Value of Tests | 1 | 2022 | 1035 | 0.160 |
Why?
|
| Diet | 1 | 2023 | 636 | 0.160 |
Why?
|
| Apoptosis | 1 | 2024 | 1040 | 0.160 |
Why?
|
| Diagnostic Errors | 1 | 2019 | 98 | 0.160 |
Why?
|
| Energy Metabolism | 1 | 2021 | 350 | 0.150 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2021 | 678 | 0.140 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2022 | 1480 | 0.120 |
Why?
|
| Disease Models, Animal | 1 | 2021 | 2080 | 0.110 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2019 | 2049 | 0.090 |
Why?
|
| Aquaporin 2 | 1 | 2005 | 1 | 0.060 |
Why?
|
| R-SNARE Proteins | 1 | 2005 | 5 | 0.060 |
Why?
|
| Secretory Vesicles | 1 | 2005 | 22 | 0.060 |
Why?
|
| Biotinylation | 1 | 2005 | 38 | 0.060 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2005 | 82 | 0.060 |
Why?
|
| Chickens | 1 | 2005 | 91 | 0.060 |
Why?
|
| Immunoblotting | 1 | 2005 | 190 | 0.060 |
Why?
|
| Chromatography, Liquid | 1 | 2005 | 120 | 0.060 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2005 | 571 | 0.050 |
Why?
|
| Protein Domains | 1 | 2024 | 140 | 0.050 |
Why?
|
| Kinetics | 1 | 2025 | 737 | 0.050 |
Why?
|
| Crystallography, X-Ray | 1 | 2024 | 422 | 0.050 |
Why?
|
| Structure-Activity Relationship | 1 | 2022 | 376 | 0.050 |
Why?
|
| Binding Sites | 1 | 2024 | 870 | 0.050 |
Why?
|
| Rats | 1 | 2005 | 1918 | 0.050 |
Why?
|
| Amino Acid Sequence | 1 | 2024 | 1580 | 0.040 |
Why?
|
| Membrane Proteins | 1 | 2005 | 844 | 0.040 |
Why?
|
| Contrast Media | 1 | 2019 | 414 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2019 | 910 | 0.030 |
Why?
|
| Mutation | 1 | 2021 | 2464 | 0.030 |
Why?
|
| Child | 1 | 2019 | 4328 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 5181 | 0.020 |
Why?
|
| Adolescent | 1 | 2019 | 5949 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2019 | 6125 | 0.020 |
Why?
|
| Aged | 1 | 2019 | 13553 | 0.010 |
Why?
|
| Adult | 1 | 2019 | 15949 | 0.010 |
Why?
|
| Middle Aged | 1 | 2019 | 16500 | 0.010 |
Why?
|
| Male | 1 | 2019 | 27914 | 0.010 |
Why?
|
| Female | 1 | 2019 | 31191 | 0.010 |
Why?
|